Literature DB >> 29787002

HPV 16 and 18 viral loads are greater in patients with high-grade cervical epithelial lesions.

M Ramirez-Flores, I Delgado-Enciso, A R G Fernandez-Salinas, L L Valdez-Velazquez, J Guzman-Esquivel, L M Baltazar-Rodriguez.   

Abstract

BACKGROUND: Cervical cancer is the second most common cancer in women worldwide. High-risk infection with HPV type 16 or type 18 is the most important risk factor associated with the development of cervical cancer. AIMS: To determine the viral load of HPV-16 and HPV-1 8 in samples from women with cervical epithelial lesion in the State of Colima, Mexico.
MATERIALS AND METHODS: A cross-sectional analytic study was conducted that included 45 samples positive for HPV- 16 and 45 samples positive for HPV-1 8 from patients with cervical cancer or precursor lesion. Real time PCR was employed to determine the number of copies /101 cells. Viral load was determined in the two groups of patients and correlated with tumor grade.
RESULTS: THe authors found that the HPV-1 6 viral load was greater than that of HPV-18 through a Mann-Whitney U analysis, resulting in ap = 0.000; as the malignancy of the cervical lesion progressed, the viral load increased, and HPV-16 showed a moderate positive association with an r = 0.509 and a p = 0.000, whereas HPV-18 showed a weak positive correlation with an r = 0.372 and a p = 0.0 12.
CONCLUSIONS: The viral load of HPV-16 was greater than that of HPV-18. The HPV-16 viral load had a moderate positive association in relation to cervical lesion severity, whereas the viral load of HPV- 18 had a weak positive correlation with respect to the cervical lesion grade.

Entities:  

Mesh:

Year:  2016        PMID: 29787002

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  1 in total

1.  Association of HPV16 and 18 genomic copies with histological grades of cervical lesions.

Authors:  Negar Joharinia; Ali Farhadi; Seyed Younes Hosseini; Akbar Safaei; Jamal Sarvari
Journal:  Virusdisease       Date:  2019-07-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.